PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pharmacy, Royal Prince Alfred Hospital, Sydney, Australia.\', \'School of Molecular Science, College of Science, La Trobe University, Melbourne, Australia.\', \'ANZAC Research Institute, Sydney, Australia.\', \'South Western Sydney Clinical School, University of New South Wales, Ingham Institute for Applied Medical Research, Sydney, Australia.\', \'Department of Medicine, Melbourne Medical School, University of Melbourne, Melbourne, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1042/CS20201268
?:hasPublicationType
?:journal
  • Clinical science (London, England : 1979)
is ?:pmid of
?:pmid
?:pmid
  • 33284956
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • ACE2: from protection of liver disease to propagation of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all